Navigation Links
Inovio Pharmaceuticals' Partner ChronTech Initiates Phase II Clinical Trial of Hepatitis C Virus DNA Vaccine Using Inovio's Electroporation Delivery Technology
Date:3/14/2011

rnment healthcare proposals and other factors set forth in our Annual Report on Form 10-K for the year ended December 31, 2009, our Form 10-Q for the nine months ended September 30, 2010, and other regulatory filings from time to time. There can be no assurance that any product in Inovio's pipeline will be successfully developed or manufactured, that final results of clinical studies will be supportive of regulatory approvals required to market licensed products, or that any of the forward-looking information provided herein will be proven accurate.

CONTACTS:

Investors: Bernie Hertel, Inovio Pharmaceuticals 858-410-3101 bhertel@inovio.com

Media:   Jeff Richardson, Richardson & Associates 805-491-8313 jeff@richardsonglobalpr.com

(Logo:  https://photos.prnewswire.com/prnh/20110127/LA37605LOGO)


'/>"/>
SOURCE Inovio Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Inovio Pharmaceuticals to Present at ROTH 23rd Annual Growth Stock Conference
2. Inovio Pharmaceuticals to Present at Cowen & Co. Health Care Conference
3. Inovio Pharmaceuticals to Present at Partnering and Scientific Conferences
4. Inovio Pharmaceuticals Unveils Needle-free, Contactless Electroporation Technology for DNA Vaccine Delivery
5. Inovio Pharmaceuticals Dual-Antigen SynCon™ DNA Vaccine for Prostate Cancer Induces Robust Responses in Preclinical Trial
6. University of Southampton and Inovio Pharmaceuticals Initiate Phase 2 Clinical Study to Evaluate Leukemia DNA Vaccine Using Electroporation Delivery Technology
7. Inovio Pharmaceuticals Closes $24.3 Million Registered Offering
8. Onyx Pharmaceuticals to Present at the Barclays Capital 2011 Global Healthcare Conference
9. Ferring Pharmaceuticals, Inc. Congratulates R&B and Pop Icon Gloria Gaynor, Named Woman of the Year by Arthritis Foundation
10. Conatus Pharmaceuticals Will Display HCV Clinical Trial Data at the International Liver Congress™ (EASL) in March
11. Arena Pharmaceuticals Announces Fourth Quarter and Full Year 2010 Financial Results and Reviews Recent Developments
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/28/2014)... , Aug. 28, 2014 ... research report is available in its ... in Asia-Pacific Markets to 2020 - ... Need in Newly Diagnosed and Recurrent ... Glioblastoma Multiforme ...
(Date:8/28/2014)... MEETING, Pa. , Aug. 28, 2014 /PRNewswire-USNewswire/ ... community, patients, and media, both for the promise ... patient safety. The quick deployment of surgical robots ... technology are prompting facilities to evaluate their robotic ... the entire surgical team.    ECRI ...
(Date:8/28/2014)... NEW YORK , Aug. 28, ... a new market research report is ... ADHD Therapeutics to 2020 - Broadened ... to Drive Market Growth despite Patent ... ADHD Therapeutics to ...
Breaking Medicine Technology:Glioblastoma Multiforme Therapeutics in Asia-Pacific Markets to 2020 - Novel Therapeutic Approaches Target High Unmet Need in Newly Diagnosed and Recurrent GBM 2Glioblastoma Multiforme Therapeutics in Asia-Pacific Markets to 2020 - Novel Therapeutic Approaches Target High Unmet Need in Newly Diagnosed and Recurrent GBM 3Glioblastoma Multiforme Therapeutics in Asia-Pacific Markets to 2020 - Novel Therapeutic Approaches Target High Unmet Need in Newly Diagnosed and Recurrent GBM 4Glioblastoma Multiforme Therapeutics in Asia-Pacific Markets to 2020 - Novel Therapeutic Approaches Target High Unmet Need in Newly Diagnosed and Recurrent GBM 5Glioblastoma Multiforme Therapeutics in Asia-Pacific Markets to 2020 - Novel Therapeutic Approaches Target High Unmet Need in Newly Diagnosed and Recurrent GBM 6Glioblastoma Multiforme Therapeutics in Asia-Pacific Markets to 2020 - Novel Therapeutic Approaches Target High Unmet Need in Newly Diagnosed and Recurrent GBM 7Glioblastoma Multiforme Therapeutics in Asia-Pacific Markets to 2020 - Novel Therapeutic Approaches Target High Unmet Need in Newly Diagnosed and Recurrent GBM 8Glioblastoma Multiforme Therapeutics in Asia-Pacific Markets to 2020 - Novel Therapeutic Approaches Target High Unmet Need in Newly Diagnosed and Recurrent GBM 9Surgical Robot Risk and Safety: ECRI Institute and Hartford Hospital Launch New Education Series 2Surgical Robot Risk and Safety: ECRI Institute and Hartford Hospital Launch New Education Series 3Surgical Robot Risk and Safety: ECRI Institute and Hartford Hospital Launch New Education Series 4Surgical Robot Risk and Safety: ECRI Institute and Hartford Hospital Launch New Education Series 5ADHD Therapeutics to 2020 - Broadened Diagnostic Criteria and Growing Adult Prevalence to Drive Market Growth despite Patent Expirations 2ADHD Therapeutics to 2020 - Broadened Diagnostic Criteria and Growing Adult Prevalence to Drive Market Growth despite Patent Expirations 3ADHD Therapeutics to 2020 - Broadened Diagnostic Criteria and Growing Adult Prevalence to Drive Market Growth despite Patent Expirations 4ADHD Therapeutics to 2020 - Broadened Diagnostic Criteria and Growing Adult Prevalence to Drive Market Growth despite Patent Expirations 5ADHD Therapeutics to 2020 - Broadened Diagnostic Criteria and Growing Adult Prevalence to Drive Market Growth despite Patent Expirations 6ADHD Therapeutics to 2020 - Broadened Diagnostic Criteria and Growing Adult Prevalence to Drive Market Growth despite Patent Expirations 7ADHD Therapeutics to 2020 - Broadened Diagnostic Criteria and Growing Adult Prevalence to Drive Market Growth despite Patent Expirations 8
... and TARRYTOWN, N.Y., March 19, 2012   Siemens Healthcare Diagnostics ... for Clinical Pathology (ASCP) have awarded ... and graduate medical laboratory students for the 2011-2012 academic year. ... was established in 2003 to address the nation,s ...
... 2012 Avaxia Biologics, Inc., a privately-held biotech company ... therapeutics for the treatment of gastrointestinal diseases, is proud ... of funding from the National Institutes of Health for ... been awarded a Phase II Small Business Innovation Research ...
Cached Medicine Technology:Siemens and ASCP Award Over 100 Scholarships to Medical Laboratory Students in 2012 2Siemens and ASCP Award Over 100 Scholarships to Medical Laboratory Students in 2012 3Avaxia Biologics Awarded $1.5 Million Phase II SBIR Grant from NIH to Develop Oral Antibody Therapeutic for Inflammatory Bowel Disease 2
(Date:8/29/2014)... 2014 A recent article brings ... overexposure to the sun are well known, and yet many ... damage often doesn’t manifest itself physically on the skin until ... Thomas Leveritt showed, even if it can’t be seen the ... camera in order to show ordinary people on the street ...
(Date:8/29/2014)... 29, 2014 In 2014, industry veterans ... merging or selling their practices. The Deloitte’s 2013 Survey ... to retire earlier than planned in the next two ... physicians are concerned about the future of their profession ... general, physicians are cynical and worried about the future ...
(Date:8/29/2014)... Pearl River, NY (PRWEB) August 29, 2014 ... happier? Create incredible value proposition and provide top ... has recently expanded his practice by partnering with ... Dr. David Greuner, and launching two new websites! ... of breast, body and face surgical procedures. Some ...
(Date:8/29/2014)... In short, minimally invasive spine surgeries ... of Orthopedic and Laser Spine Surgery , use ... Problems with the discs, nerves and boney abnormalities ... treatment needs that can be offered from this type ... small incision and intervention that exposes the patient at ...
(Date:8/29/2014)... OR (PRWEB) August 29, 2014 What is ... Namie defines bullying as the “repeated, health- harming, mistreatment by ... verbal abuse, intimidation, sabotage, humiliation, or threats. It is ... violence.” Namie continued, “truth be told, bullying is a ... form of workplace violence that stops just short of the ...
Breaking Medicine News(10 mins):Health News:Artist Uses Ultraviolet Camera to Reveal Hidden Sun Damage 2Health News:Artist Uses Ultraviolet Camera to Reveal Hidden Sun Damage 3Health News:Planning for Retiring, Selling, or Closing Down the Practice? Help is at Hand 2Health News:Planning for Retiring, Selling, or Closing Down the Practice? Help is at Hand 3Health News:Planning for Retiring, Selling, or Closing Down the Practice? Help is at Hand 4Health News:Michael Fiorillo’s Advanced Plastic Surgery Center Expansion – New Vein Specialist and Websites Launch 2Health News:Michael Fiorillo’s Advanced Plastic Surgery Center Expansion – New Vein Specialist and Websites Launch 3Health News:Advancements in Spine Surgery Offered by this Modern Florida Surgery Group are Cutting Out Historically Demanding Recovery Times 2Health News:Bullying Expert Dr. Gary Namie discusses NCAA and Professional Sports with Sports Conflict Institute 2Health News:Bullying Expert Dr. Gary Namie discusses NCAA and Professional Sports with Sports Conflict Institute 3
... Research Center have cleared a major technical hurdle to making ... other blood cancers. In a study published in the ... and colleagues describe the first use of a method to ... of cord blood in the laboratory that were then infused ...
... , SUNDAY, Jan. 17 (HealthDay News) -- Giving a ... a stronger immune response than injected vaccines, say U.S. ... less vaccine to prompt an immune response. , Scarification ... the first smallpox vaccinations. Nearly all modern vaccines are ...
... ... patients by advocating for physician patient relationships which ensure optimal patient care and well ... of guidelines such as breast cancer screening that can negatively impact patients. , ... (PRWEB) January 17, 2010 ...
... - More relief goods, staff arrive, but challenges remain , ... - Agency reports "race against clock" to save lives in Haiti ... 16 World Vision relief workers, in a race against ... began arriving in Haiti,s quake-ravaged capital city yesterday.  Meanwhile, World Vision staff ...
... , WASHINGTON , ... International Development (USAID) Bureau for Global Health is sending additional ... rising medical needs.  Reports indicate that thousands of individuals in ... following Tuesday,s earthquake. , (Logo:   http://www.newscom.com/cgi-bin/prnh/20091022/USAIDLOGO ) , ...
... ... their new online store, featuring free shipping and the guaranteed lowest price on fitness equipment. ... Phoenix, AZ (PRWEB) January ... to announce the launch of their new online store, featuring free shipping and the guaranteed ...
Cached Medicine News:Health News:First successful use of expanded umbilical-cord blood units to treat leukemia 2Health News:First successful use of expanded umbilical-cord blood units to treat leukemia 3Health News:Immune Response Better With Skin Scratch Vaccination 2Health News:Southern Medical Association Takes Position on Breast Cancer Screening 2Health News:Southern Medical Association Takes Position on Breast Cancer Screening 3Health News:Southern Medical Association Takes Position on Breast Cancer Screening 4Health News:HAITI QUAKE: World Vision Situation Update 2Health News:HAITI QUAKE: World Vision Situation Update 3Health News:HAITI QUAKE: World Vision Situation Update 4Health News:USAID's Global Health Bureau Responds to Haiti's Medical Crisis 2Health News:USAID's Global Health Bureau Responds to Haiti's Medical Crisis 3Health News:Fitness4HomeOnline.com Features Fitness Equipment Online with Free Shipping and Guaranteed Lowest Price 2
The 920M PLUS handheld pulseoximeter provides on-the-spot bloodoximetry and heart rate readings....
Rad-5v signal extraction pulse oximeter™...
The PalmSAT® 2500 series are small, yet versatile digital pulse oximeters for accurate assessment of blood oxygen saturation and pulse rate. Choose alarm or non-alarm versions for your portable ...
... The WristOx® 3100 is a ... to be worn comfortably on ... monitoring daily activities and for ... of the WristOx is intended ...
Medicine Products: